25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

AMPH (Amphastar) Stock Analysis
Buy, Hold or Sell?

Let's analyze Amphastar together

I guess you are interested in Amphastar P. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

  • 📊 Fundamental Analysis (FA) – Amphastar’s Financial Insights
  • 📈 Technical Analysis (TA) – Amphastar’s Price Targets

I'm going to help you getting a better view of Amphastar P. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about Amphastar P

I send you an email if I find something interesting about Amphastar P.

1. Quick Overview

1.1. Quick analysis of Amphastar (30 sec.)










1.2. What can you expect buying and holding a share of Amphastar? (30 sec.)

How much money do you get?

How much money do you get?
$0.00
When do you have the money?
1 year
How often do you get paid?
25.0%

What is your share worth?

Current worth
$15.74
Expected worth in 1 year
$17.77
How sure are you?
72.5%

+ What do you gain per year?

Total Gains per Share
$2.03
Return On Investment
7.5%

For what price can you sell your share?

Current Price per Share
$27.00
Expected price per share
$20.43 - $31.26
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of Amphastar (5 min.)




Live pricePrice per Share (EOD)
$27.00
Intrinsic Value Per Share
$15.41 - $54.04
Total Value Per Share
$31.15 - $69.78

2.2. Growth of Amphastar (5 min.)




Is Amphastar growing?

Current yearPrevious yearGrowGrow %
How rich?$757.4m$655m$87.1m11.7%

How much money is Amphastar making?

Current yearPrevious yearGrowGrow %
Making money$33.6m$41.6m-$7.9m-23.6%
Net Profit Margin18.6%23.4%--

How much money comes from the company's main activities?

2.3. Financial Health of Amphastar (5 min.)




3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of Amphastar?

Welcome investor! Amphastar's management wants to use your money to grow the business. In return you get a share of Amphastar.

First you should know what it really means to hold a share of Amphastar. And how you can make/lose money.

Speculation

The Price per Share of Amphastar is $27.00. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Amphastar.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Amphastar, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $15.74. Based on the TTM, the Book Value Change Per Share is $0.51 per quarter. Based on the YOY, the Book Value Change Per Share is $0.65 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Amphastar.

How much money are you going to get?

 MRQTTMYOY3Y5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps0.642.4%0.672.5%0.782.9%0.652.4%0.491.8%0.281.0%
Usd Book Value Change Per Share0.682.5%0.511.9%0.652.4%0.532.0%0.311.2%0.240.9%
Usd Dividend Per Share0.000.0%0.000.0%0.010.0%0.030.1%0.020.1%0.050.2%
Usd Total Gains Per Share0.682.5%0.511.9%0.662.5%0.562.1%0.331.2%0.291.1%
Usd Price Per Share22.96-34.40-47.94-40.04-33.54-25.57-
Price to Earnings Ratio8.90-12.87-15.61-16.28-18.14-29.52-
Price-to-Total Gains Ratio33.76-311.50--544.07--49.27--9.39--141.25-
Price to Book Ratio1.46-2.37-3.92-3.30-3.02-2.71-
Price-to-Total Gains Ratio33.76-311.50--544.07--49.27--9.39--141.25-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share27
Number of shares37
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.02
Usd Book Value Change Per Share0.510.31
Usd Total Gains Per Share0.510.33
Gains per Quarter (37 shares)18.8012.31
Gains per Year (37 shares)75.2149.24
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10756534639
2015014069388
302262158139137
4030129011186186
5037636514232235
6045144017279284
7052751520325333
8060259022372382
9067766525418431
10075274028464480

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share4.00.00.0100.0%12.00.00.0100.0%19.01.00.095.0%33.07.00.082.5%40.014.00.074.1%
Book Value Change Per Share4.00.00.0100.0%11.01.00.091.7%16.04.00.080.0%28.012.00.070.0%33.016.05.061.1%
Dividend per Share0.00.04.00.0%5.00.07.041.7%5.00.015.025.0%10.00.030.025.0%11.00.043.020.4%
Total Gains per Share4.00.00.0100.0%11.01.00.091.7%16.04.00.080.0%29.011.00.072.5%35.014.05.064.8%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of Amphastar P compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-3Y+/-5 Year+/-10 Year+/-
Book Value Change Per Share--0.6800.508+34%0.652+4%0.530+28%0.314+117%0.240+183%
Book Value Per Share--15.73914.724+7%12.372+27%12.486+26%11.148+41%9.259+70%
Current Ratio--3.2933.188+3%2.494+32%2.989+10%2.953+11%2.825+17%
Debt To Asset Ratio--0.5310.5330%0.572-7%0.490+8%0.417+27%0.340+56%
Debt To Equity Ratio--1.1331.144-1%1.348-16%1.047+8%0.817+39%0.596+90%
Dividend Per Share----0%0.010-100%0.032-100%0.019-100%0.047-100%
Enterprise Value--478918880.0001136590095.000-58%1932318630.000-75%1622967913.333-70%1425853682.500-66%1109577743.650-57%
Eps--0.6450.665-3%0.785-18%0.6470%0.487+32%0.277+133%
Ev To Ebitda Ratio--1.9364.478-57%6.814-72%7.787-75%103.666-98%111.359-98%
Ev To Sales Ratio--0.6861.552-56%2.713-75%2.522-73%2.549-73%2.683-74%
Free Cash Flow Per Share--0.5200.555-6%0.841-38%0.624-17%0.497+5%0.261+99%
Free Cash Flow To Equity Per Share---0.1080.052-305%0.905-112%1.081-110%0.733-115%0.385-128%
Gross Profit Margin--0.6700.676-1%0.794-16%0.741-10%0.710-6%0.909-26%
Intrinsic Value_10Y_max--54.042----------
Intrinsic Value_10Y_min--15.410----------
Intrinsic Value_1Y_max--2.924----------
Intrinsic Value_1Y_min--1.137----------
Intrinsic Value_3Y_max--10.685----------
Intrinsic Value_3Y_min--3.789----------
Intrinsic Value_5Y_max--20.734----------
Intrinsic Value_5Y_min--6.830----------
Market Cap1255367700.000+12%1105018880.0001750276595.000-37%2542095880.000-57%2091880163.333-47%1736640332.500-36%1290345093.650-14%
Net Profit Margin--0.1780.186-4%0.234-24%0.202-12%0.165+8%0.104+72%
Operating Margin--0.2620.259+1%0.328-20%0.274-4%0.222+18%0.116+126%
Operating Ratio--0.7580.749+1%0.682+11%0.730+4%0.784-3%0.887-15%
Pb Ratio1.715+15%1.4592.371-38%3.919-63%3.297-56%3.017-52%2.706-46%
Pe Ratio10.469+15%8.90312.874-31%15.613-43%16.280-45%18.139-51%29.517-70%
Price Per Share27.000+15%22.96034.403-33%47.938-52%40.038-43%33.539-32%25.570-10%
Price To Free Cash Flow Ratio12.981+15%11.03817.146-36%22.264-50%21.318-48%10.312+7%-120.475+1191%
Price To Total Gains Ratio39.699+15%33.759311.503-89%-544.068+1712%-49.267+246%-9.387+128%-141.251+518%
Quick Ratio--2.3172.459-6%2.171+7%2.366-2%2.213+5%1.857+25%
Return On Assets--0.0190.021-10%0.027-29%0.026-27%0.023-17%0.015+31%
Return On Equity--0.0410.046-10%0.064-36%0.052-21%0.042-4%0.026+59%
Total Gains Per Share--0.6800.508+34%0.662+3%0.561+21%0.333+104%0.287+137%
Usd Book Value--757482000.000742185250.000+2%655065750.000+16%646719916.667+17%571651850.000+33%462343825.000+64%
Usd Book Value Change Per Share--0.6800.508+34%0.652+4%0.530+28%0.314+117%0.240+183%
Usd Book Value Per Share--15.73914.724+7%12.372+27%12.486+26%11.148+41%9.259+70%
Usd Dividend Per Share----0%0.010-100%0.032-100%0.019-100%0.047-100%
Usd Enterprise Value--478918880.0001136590095.000-58%1932318630.000-75%1622967913.333-70%1425853682.500-66%1109577743.650-57%
Usd Eps--0.6450.665-3%0.785-18%0.6470%0.487+32%0.277+133%
Usd Free Cash Flow--25027000.00028047250.000-11%44531500.000-44%32563083.333-23%25675700.000-3%13436775.000+86%
Usd Free Cash Flow Per Share--0.5200.555-6%0.841-38%0.624-17%0.497+5%0.261+99%
Usd Free Cash Flow To Equity Per Share---0.1080.052-305%0.905-112%1.081-110%0.733-115%0.385-128%
Usd Market Cap1255367700.000+12%1105018880.0001750276595.000-37%2542095880.000-57%2091880163.333-47%1736640332.500-36%1290345093.650-14%
Usd Price Per Share27.000+15%22.96034.403-33%47.938-52%40.038-43%33.539-32%25.570-10%
Usd Profit--31030000.00033677000.000-8%41628750.000-25%33597166.667-8%25226350.000+23%14275200.000+117%
Usd Revenue--174414000.000180071000.000-3%178222750.000-2%164505083.333+6%141750800.000+23%106466325.000+64%
Usd Total Gains Per Share--0.6800.508+34%0.662+3%0.561+21%0.333+104%0.287+137%
 EOD+4 -4MRQTTM+15 -23YOY+16 -243Y+14 -265Y+22 -1810Y+25 -15

3.3 Fundamental Score

Let's check the fundamental score of Amphastar P based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-1510.469
Price to Book Ratio (EOD)Between0-11.715
Net Profit Margin (MRQ)Greater than00.178
Operating Margin (MRQ)Greater than00.262
Quick Ratio (MRQ)Greater than12.317
Current Ratio (MRQ)Greater than13.293
Debt to Asset Ratio (MRQ)Less than10.531
Debt to Equity Ratio (MRQ)Less than11.133
Return on Equity (MRQ)Greater than0.150.041
Return on Assets (MRQ)Greater than0.050.019
Total6/10 (60.0%)

3.4 Technical Score

Let's check the technical score of Amphastar P based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
OpenGreater thanClose27.300
Total1/1 (100.0%)

4. In-depth Analysis

4.1 About Amphastar P

Amphastar Pharmaceuticals, Inc., a bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France. It offers BAQSIMI, a nasal spray for the treatment of severe hypoglycemia; Primatene Mist, an over-the-counter epinephrine inhalation product for the temporary relief of mild symptoms of intermittent asthma; Enoxaparin to prevent and treat deep vein thrombosis; REXTOVY and Naloxone for opioid overdose; Glucagon for injection emergency kit; and Cortrosyn, for use as a diagnostic agent in the screening of patients with adrenocortical insufficiency. The company also provides Amphadase, a bovine-sourced hyaluronidase injection; Epinephrine injection for allergic reactions; Lidocaine jelly, an anesthetic product for urological procedures; Lidocaine topical solution for various procedures; Phytonadione injection, a vitamin K1 injection for newborn babies; emergency syringe products; morphine injection for use with patient-controlled analgesia pumps; and Lorazepam injection for surgery and medical procedures. In addition, it offers Neostigmine methylsulfate injection to treat myasthenia gravis and to reverse the effects of muscle relaxants; Isoproterenol hydrochloride injection for mild or transient episodes of heart block; Ganirelix Acetate injection for the inhibition of premature luteinizing hormone surges; Vasopressin to increase blood pressure; and Regadenoson, a stress agent for radionuclide myocardial perfusion imaging, as well as Albuterol Sulfate inhalation aerosol. Further, the company distributes recombinant human insulin APIs and porcine insulin API. Additionally, it develops generic product candidates, such as injectable, inhalation, and analytical technologies; biosimial product candidates; and intranasal epinephrine for the treatment of allergic reactions. The company was founded in 1996 and is headquartered in Rancho Cucamonga, California.

Fundamental data was last updated by Penke on 2025-08-23 10:10:06.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge profit.
Using its assets, the company is less efficient in making profit.
Using its investors money, the company is inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very efficient.
The company is efficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is able to pay all its debts by selling its assets.
The company is able to pay all its debts with equity.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is underpriced.
Based on how much money comes from the company's main activities, the company is underpriced.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profit Amphastar earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Amphastar to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Net Profit Margin of 17.8% means that $0.18 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Amphastar P:

  • The MRQ is 17.8%. The company is making a huge profit. +2
  • The TTM is 18.6%. The company is making a huge profit. +2
Trends
Current periodCompared to+/- 
MRQ17.8%TTM18.6%-0.8%
TTM18.6%YOY23.4%-4.8%
TTM18.6%5Y16.5%+2.1%
5Y16.5%10Y10.4%+6.2%
4.3.1.2. Return on Assets

Shows how efficient Amphastar is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Amphastar to the Drug Manufacturers - Specialty & Generic industry mean.
  • 1.9% Return on Assets means that Amphastar generated $0.02 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Amphastar P:

  • The MRQ is 1.9%. Using its assets, the company is less efficient in making profit.
  • The TTM is 2.1%. Using its assets, the company is less efficient in making profit.
Trends
Current periodCompared to+/- 
MRQ1.9%TTM2.1%-0.2%
TTM2.1%YOY2.7%-0.6%
TTM2.1%5Y2.3%-0.2%
5Y2.3%10Y1.5%+0.9%
4.3.1.3. Return on Equity

Shows how efficient Amphastar is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Amphastar to the Drug Manufacturers - Specialty & Generic industry mean.
  • 4.1% Return on Equity means Amphastar generated $0.04 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Amphastar P:

  • The MRQ is 4.1%. Using its investors money, the company is inefficient in making profit. -1
  • The TTM is 4.6%. Using its investors money, the company is inefficient in making profit. -1
Trends
Current periodCompared to+/- 
MRQ4.1%TTM4.6%-0.5%
TTM4.6%YOY6.4%-1.9%
TTM4.6%5Y4.2%+0.3%
5Y4.2%10Y2.6%+1.7%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of Amphastar P.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

Measures how efficient Amphastar is operating .

  • Measures how much profit Amphastar makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Amphastar to the Drug Manufacturers - Specialty & Generic industry mean.
  • An Operating Margin of 26.2% means the company generated $0.26  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Amphastar P:

  • The MRQ is 26.2%. The company is operating very efficient. +2
  • The TTM is 25.9%. The company is operating very efficient. +2
Trends
Current periodCompared to+/- 
MRQ26.2%TTM25.9%+0.2%
TTM25.9%YOY32.8%-6.9%
TTM25.9%5Y22.2%+3.7%
5Y22.2%10Y11.6%+10.6%
4.3.2.2. Operating Ratio

Measures how efficient Amphastar is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • An Operation Ratio of 0.76 means that the operating costs are $0.76 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Amphastar P:

  • The MRQ is 0.758. The company is efficient in keeping operating costs low. +1
  • The TTM is 0.749. The company is efficient in keeping operating costs low. +1
Trends
Current periodCompared to+/- 
MRQ0.758TTM0.749+0.009
TTM0.749YOY0.682+0.066
TTM0.7495Y0.784-0.035
5Y0.78410Y0.887-0.103
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of Amphastar P.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if Amphastar is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • A Current Ratio of 3.29 means the company has $3.29 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Amphastar P:

  • The MRQ is 3.293. The company is very able to pay all its short-term debts. +2
  • The TTM is 3.188. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ3.293TTM3.188+0.104
TTM3.188YOY2.494+0.694
TTM3.1885Y2.953+0.235
5Y2.95310Y2.825+0.128
4.4.3.2. Quick Ratio

Measures if Amphastar is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Amphastar to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Quick Ratio of 2.32 means the company can pay off $2.32 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Amphastar P:

  • The MRQ is 2.317. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 2.459. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ2.317TTM2.459-0.142
TTM2.459YOY2.171+0.288
TTM2.4595Y2.213+0.246
5Y2.21310Y1.857+0.356
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of Amphastar P.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much % of Amphastar assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Amphastar to Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Asset Ratio of 0.53 means that Amphastar assets are financed with 53.1% credit (debt) and the remaining percentage (100% - 53.1%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Amphastar P:

  • The MRQ is 0.531. The company is able to pay all its debts by selling its assets. +1
  • The TTM is 0.533. The company is able to pay all its debts by selling its assets. +1
Trends
Current periodCompared to+/- 
MRQ0.531TTM0.533-0.002
TTM0.533YOY0.572-0.038
TTM0.5335Y0.417+0.116
5Y0.41710Y0.340+0.077
4.5.4.2. Debt to Equity Ratio

Measures if Amphastar is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Amphastar to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Equity ratio of 113.3% means that company has $1.13 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Amphastar P:

  • The MRQ is 1.133. The company is able to pay all its debts with equity. +1
  • The TTM is 1.144. The company is able to pay all its debts with equity. +1
Trends
Current periodCompared to+/- 
MRQ1.133TTM1.144-0.011
TTM1.144YOY1.348-0.205
TTM1.1445Y0.817+0.327
5Y0.81710Y0.596+0.220
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Amphastar generates.

  • Above 15 is considered overpriced but always compare Amphastar to the Drug Manufacturers - Specialty & Generic industry mean.
  • A PE ratio of 8.90 means the investor is paying $8.90 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Amphastar P:

  • The EOD is 10.469. Based on the earnings, the company is underpriced. +1
  • The MRQ is 8.903. Based on the earnings, the company is underpriced. +1
  • The TTM is 12.874. Based on the earnings, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD10.469MRQ8.903+1.567
MRQ8.903TTM12.874-3.971
TTM12.874YOY15.613-2.740
TTM12.8745Y18.139-5.265
5Y18.13910Y29.517-11.378
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Amphastar P:

  • The EOD is 12.981. Based on how much money comes from the company's main activities, the company is cheap. +2
  • The MRQ is 11.038. Based on how much money comes from the company's main activities, the company is cheap. +2
  • The TTM is 17.146. Based on how much money comes from the company's main activities, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD12.981MRQ11.038+1.942
MRQ11.038TTM17.146-6.108
TTM17.146YOY22.264-5.118
TTM17.1465Y10.312+6.834
5Y10.31210Y-120.475+130.787
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price of Amphastar is to cheap or to expensive compared to its book value.

Let's take a look of the Price to Book Ratio trends of Amphastar P:

  • The EOD is 1.715. Based on the equity, the company is underpriced. +1
  • The MRQ is 1.459. Based on the equity, the company is underpriced. +1
  • The TTM is 2.371. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD1.715MRQ1.459+0.257
MRQ1.459TTM2.371-0.912
TTM2.371YOY3.919-1.548
TTM2.3715Y3.017-0.647
5Y3.01710Y2.706+0.311
4.6.2. Total Gains per Share

2.4. Latest News of Amphastar P

Does Amphastar P still have the same value as the quarterly reports suggest? Recent changes may be an indication that the value of the company is changing. Read the news from Amphastar P to keep up to date. Note: the news is often already included in the price.

DateTitleRead
2025-09-09
11:12
Amphastar Pharmaceuticals Inc (NASDAQ:AMPH) Presents a Compelling Value Investment CaseRead
2025-08-22
20:59
Bullish Two Hundred Day Moving Average Cross - AMPHRead

4.7 Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of Amphastar P.

4.8.1. Institutions holding Amphastar P

Institutions are holding 72.417% of the shares of Amphastar P.

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2025-03-31BlackRock Inc13.22340.00376147658298360.4877
2025-06-30Vanguard Group Inc5.77960.001268695026404610.8979
2025-06-30TD Asset Management Inc4.37710.03992034930-177212-8.0109
2025-06-30Dimensional Fund Advisors, Inc.3.49940.0087162688427052419.9449
2025-03-31State Street Corp3.45150.0019160461485040.5328
2025-06-30Fuller & Thaler Asset Management Inc2.71830.105912637721740.0138
2025-06-30TD Global Investment Solutions – TD Epoch2.67020.14751241369-19938-1.5807
2025-06-30BTIM Corp2.53050.19271176453-39171-3.2223
2025-03-31Marshall Wace Asset Management Ltd2.21920.038103172242301669.4943
2025-03-31Geode Capital Management, LLC2.05430.0022955076389954.2567
2025-03-31Millennium Management LLC1.86820.0134868551611995238.5425
2025-03-31Northern Trust Corp1.27860.0026594437-18733-3.0551
2025-03-31Federated Hermes Inc1.25860.0366585115-238372-28.9467
2025-03-31Morgan Stanley - Brokerage Accounts1.1230.0011522112-109962-17.397
2025-03-31Renaissance Technologies Corp1.06470.0217495000-30500-5.804
2025-03-31Pacer Advisors, INC.1.03120.0325479390-870978-64.4993
2025-03-31Boston Partners Global Investors, Inc0.910.0144423070-3566-0.8358
2025-03-31Granite Investment Partners, LLC0.80830.5537375778-20924-5.2745
2025-03-31Amvescap Plc.0.77250.0023591436027920.1694
2025-06-30Goldman Sachs Group Inc0.76630.0011356250-50462-12.4073
Total 53.40491.220624828274+127551+0.5%

4.9.2. Funds holding Amphastar P

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2025-07-31iShares Core S&P Small-Cap ETF4.74030.057622037993860.0175
2025-03-31FullerThaler Behavioral Sm-Cp Eq R62.59720.3592120745412606211.6574
2025-03-31FullerThaler Behavioral Small-Cap Equity2.59720.3625120745412606211.6574
2025-06-30Vanguard Total Stock Mkt Idx Inv2.51440.0014116896324300026.2429
2024-12-31TD U.S. Capital Reinvestment I1.97920.8145920143-27546-2.9066
2025-07-31iShares Russell 2000 ETF1.88760.0303877558-16695-1.8669
2025-06-30Vanguard Institutional Extnd Mkt Idx Tr1.24030.0115576626-22670-3.7828
2025-07-31Boston Trust Walden Small Cap1.06840.7992496711-1110-0.223
2025-05-31Fidelity Small Cap Index0.82790.0398384902-588-0.1525
2025-07-31SPDR® Portfolio S&P 600™ Sm Cap ETF0.68280.05723174331770.0558
2025-07-31Pacer US Small Cap Cash Cows 100 ETF0.66250.1612308017-1386-0.448
2025-07-31iShares Russell 2000 Value ETF0.65130.058730278753301.7919
2025-06-30Vanguard Tax-Managed Small Cap Adm0.57950.070726943300
2025-07-31Invesco Pharmaceuticals ETF0.52332.196624330100
2025-06-30DFA US Targeted Value I0.50860.0421236460203779.4302
2025-07-31State St Russell Sm/Mid Cp® Indx SL Cl I0.46440.010421589000
2025-06-30DFA US Small Cap I0.46260.030821505100
2025-07-31iShares S&P Small-Cap 600 Growth ETF0.43340.070220149300
2025-07-31Dimensional US Targeted Value ETF0.43250.039120106400
2025-06-30Fidelity Extended Market Index0.4240.0116197143-9521-4.607
Total 25.27745.224611751682+441878+3.8%

5.3. Insider Transactions

Insiders are holding 24.016% of the shares of Amphastar P.

DateOwnerTypeAmountPricePost Transaction AmountLink
2025-08-01Floyd F PetersenSELL50020.83
2025-07-02Floyd F PetersenSELL50023.47
2025-06-02Floyd F PetersenSELL50025.67
2025-05-01Floyd F PetersenSELL50024.08
2025-04-01Floyd F PetersenSELL50028.38
2025-03-04William J PetersSELL423127.54
2024-12-12Rong ZhouSELL700044.42
2024-12-09Richard K PrinsSELL1000043.77
2024-11-12Richard K PrinsSELL500048.8
2024-11-12Rong ZhouSELL689348.88
2024-11-06William J PetersSELL742652.05
2024-11-06Yakob LiawatidewiSELL521452.05
2024-09-05Floyd F PetersenSELL300046.47
2024-08-26Rong ZhouSELL400048.35
3rd party ad coffee SUPPORTERis ad-free.

5. Financial Statements




5.1. Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2024-06-302024-09-302024-12-312025-03-312025-06-30
Net Debt  430,9626,770437,73261,208498,940-29,189469,751-609,670-139,919



5.2. Latest Balance Sheet

Balance Sheet of 2025-06-30. Currency in USD. All numbers in thousands.

Summary
Total Assets1,615,333
Total Liabilities857,851
Total Stockholder Equity757,482
 As reported
Total Liabilities 857,851
Total Stockholder Equity+ 757,482
Total Assets = 1,615,333

Assets

Total Assets1,615,333
Total Current Assets580,830
Long-term Assets1,034,503
Total Current Assets
Cash And Cash Equivalents 187,689
Short-term Investments 44,062
Net Receivables 132,982
Inventory 191,731
Other Current Assets 24,366
Total Current Assets  (as reported)580,830
Total Current Assets  (calculated)580,830
+/-0
Long-term Assets
Property Plant Equipment 354,734
Goodwill 3,397
Long Term Investments 2,047
Intangible Assets 575,102
Long-term Assets Other 28,099
Long-term Assets  (as reported)1,034,503
Long-term Assets  (calculated)963,379
+/- 71,124

Liabilities & Shareholders' Equity

Total Current Liabilities176,407
Long-term Liabilities681,444
Total Stockholder Equity757,482
Total Current Liabilities
Short-term Debt 8,806
Short Long Term Debt 927
Accounts payable 41,881
Other Current Liabilities 124,117
Total Current Liabilities  (as reported)176,407
Total Current Liabilities  (calculated)175,731
+/- 676
Long-term Liabilities
Long term Debt 607,727
Capital Lease Obligations 46,843
Long-term Liabilities Other 27,796
Long-term Liabilities  (as reported)681,444
Long-term Liabilities  (calculated)682,366
+/- 922
Total Stockholder Equity
Common Stock6
Retained Earnings 625,102
Accumulated Other Comprehensive Income -5,361
Other Stockholders Equity 137,735
Total Stockholder Equity (as reported)757,482
Total Stockholder Equity (calculated)757,482
+/-0
Other
Capital Stock6
Cash and Short Term Investments 231,751
Common Stock Shares Outstanding 48,128
Liabilities and Stockholders Equity 1,615,333
Net Debt -139,919
Net Invested Capital 1,366,136
Net Working Capital 404,423
Property Plant and Equipment Gross 645,215
Short Long Term Debt Total 47,770



5.3. Balance Sheets Structured

Currency in USD. All numbers in thousands.

 Trend2025-06-302025-03-312024-12-312024-09-302024-06-302024-03-312023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-31
> Total Assets 
0
0
0
317,477
0
0
345,397
338,748
345,109
397,268
401,133
389,370
396,502
398,929
395,027
390,136
395,006
408,586
428,837
427,738
435,612
443,997
437,766
454,665
449,782
451,646
480,642
513,563
544,718
601,301
585,636
586,971
572,831
600,058
613,718
631,236
645,738
665,745
651,677
671,529
716,238
723,719
726,695
741,987
773,656
1,378,266
1,544,633
1,512,912
1,574,317
1,491,522
1,545,178
1,577,470
1,626,276
1,615,333
1,615,3331,626,2761,577,4701,545,1781,491,5221,574,3171,512,9121,544,6331,378,266773,656741,987726,695723,719716,238671,529651,677665,745645,738631,236613,718600,058572,831586,971585,636601,301544,718513,563480,642451,646449,782454,665437,766443,997435,612427,738428,837408,586395,006390,136395,027398,929396,502389,370401,133397,268345,109338,748345,39700317,477000
   > Total Current Assets 
0
0
0
165,690
50,213
0
186,694
172,971
177,290
214,227
215,180
197,996
202,597
203,898
199,059
175,934
173,442
181,313
190,186
184,096
191,417
193,579
176,492
187,778
174,046
169,946
194,804
220,342
230,143
284,134
268,903
255,241
246,724
266,821
276,541
279,682
300,164
310,973
303,671
318,119
364,415
377,145
384,222
378,319
407,670
384,554
543,005
489,600
555,078
482,645
545,949
534,071
587,961
580,830
580,830587,961534,071545,949482,645555,078489,600543,005384,554407,670378,319384,222377,145364,415318,119303,671310,973300,164279,682276,541266,821246,724255,241268,903284,134230,143220,342194,804169,946174,046187,778176,492193,579191,417184,096190,186181,313173,442175,934199,059203,898202,597197,996215,180214,227177,290172,971186,694050,213165,690000
       Cash And Cash Equivalents 
0
0
0
50,213
-50,213
0
51,944
53,587
52,135
64,081
72,881
67,828
68,588
74,463
70,681
66,074
63,332
66,660
66,598
72,354
76,766
82,544
66,920
65,594
54,547
48,070
68,734
86,337
79,096
120,373
85,611
73,685
54,845
87,388
87,910
92,642
101,601
105,432
106,610
126,353
172,627
166,157
157,244
156,098
176,615
148,595
266,778
144,531
201,148
189,619
192,116
151,609
182,782
187,689
187,689182,782151,609192,116189,619201,148144,531266,778148,595176,615156,098157,244166,157172,627126,353106,610105,432101,60192,64287,91087,38854,84573,68585,611120,37379,09686,33768,73448,07054,54765,59466,92082,54476,76672,35466,59866,66063,33266,07470,68174,46368,58867,82872,88164,08152,13553,58751,9440-50,21350,213000
       Short-term Investments 
0
0
0
1,888
100,426
0
0
1,325
1,325
1,495
1,495
1,495
1,495
1,285
1,285
1,285
1,285
1,390
856
527
746
727
2,522
2,635
2,826
2,818
2,829
2,831
2,834
2,836
12,666
11,675
12,203
11,101
10,873
12,977
13,531
11,745
8,021
10,320
14,383
17,234
26,843
19,664
16,277
14,541
33,098
112,510
88,407
28,156
58,375
70,036
54,101
44,062
44,06254,10170,03658,37528,15688,407112,51033,09814,54116,27719,66426,84317,23414,38310,3208,02111,74513,53112,97710,87311,10112,20311,67512,6662,8362,8342,8312,8292,8182,8262,6352,5227277465278561,3901,2851,2851,2851,2851,4951,4951,4951,4951,3251,32500100,4261,888000
       Net Receivables 
0
0
0
25,909
0
0
42,406
24,585
17,714
18,598
26,604
22,852
21,653
19,832
24,998
33,233
23,081
23,128
26,550
26,777
25,892
24,123
24,152
35,996
31,883
41,279
43,816
52,163
54,930
48,823
45,255
45,376
57,784
49,862
52,382
66,005
77,938
67,893
78,090
78,804
73,166
80,810
77,099
88,804
100,638
104,715
118,990
114,943
138,898
132,079
144,984
138,036
145,394
132,982
132,982145,394138,036144,984132,079138,898114,943118,990104,715100,63888,80477,09980,81073,16678,80478,09067,89377,93866,00552,38249,86257,78445,37645,25548,82354,93052,16343,81641,27931,88335,99624,15224,12325,89226,77726,55023,12823,08133,23324,99819,83221,65322,85226,60418,59817,71424,58542,4060025,909000
       Other Current Assets 
0
0
0
38,190
0
0
32,272
24,883
28,394
25,531
27,643
24,984
27,469
29,429
30,958
5,962
4,787
3,198
5,532
4,684
9,876
11,728
13,258
19,944
22,010
16,101
14,011
9,689
14,703
12,870
15,517
14,004
13,992
13,744
16,506
11,227
9,984
27,972
10,710
9,835
9,092
14,211
19,786
17,732
17,820
17,958
14,161
12,018
11,131
10,380
20,158
20,649
20,208
24,366
24,36620,20820,64920,15810,38011,13112,01814,16117,95817,82017,73219,78614,2119,0929,83510,71027,9729,98411,22716,50613,74413,99214,00415,51712,87014,7039,68914,01116,10122,01019,94413,25811,7289,8764,6845,5323,1984,7875,96230,95829,42927,46924,98427,64325,53128,39424,88332,2720038,190000
   > Long-term Assets 
0
0
0
149,720
-50,213
0
158,703
165,777
167,819
183,041
185,953
191,374
193,905
195,031
195,968
214,202
221,564
227,273
238,651
243,642
244,195
250,418
261,274
266,887
275,736
281,700
285,838
293,221
314,575
317,167
316,733
331,730
326,107
333,237
337,177
351,554
345,574
354,772
348,006
353,410
351,823
346,574
342,473
363,668
365,986
993,712
1,001,628
1,023,312
1,019,239
1,008,877
999,229
1,043,399
1,038,315
1,034,503
1,034,5031,038,3151,043,399999,2291,008,8771,019,2391,023,3121,001,628993,712365,986363,668342,473346,574351,823353,410348,006354,772345,574351,554337,177333,237326,107331,730316,733317,167314,575293,221285,838281,700275,736266,887261,274250,418244,195243,642238,651227,273221,564214,202195,968195,031193,905191,374185,953183,041167,819165,777158,7030-50,213149,720000
       Property Plant Equipment 
0
0
0
107,366
0
0
114,429
116,619
118,565
133,991
134,112
138,289
138,276
139,251
141,181
142,161
144,684
148,647
151,952
152,944
157,389
161,720
173,046
185,339
191,915
198,241
202,526
210,418
229,410
241,188
242,517
253,548
250,208
256,096
266,830
280,709
273,139
280,299
271,015
271,491
271,369
264,727
259,798
264,573
269,986
305,510
314,112
315,643
320,391
320,572
327,518
344,627
353,759
354,734
354,734353,759344,627327,518320,572320,391315,643314,112305,510269,986264,573259,798264,727271,369271,491271,015280,299273,139280,709266,830256,096250,208253,548242,517241,188229,410210,418202,526198,241191,915185,339173,046161,720157,389152,944151,952148,647144,684142,161141,181139,251138,276138,289134,112133,991118,565116,619114,42900107,366000
       Goodwill 
0
0
0
280
0
0
280
280
280
280
4,649
4,467
3,708
3,785
3,832
3,726
4,321
4,159
4,210
3,976
4,031
4,271
4,401
4,461
4,583
4,361
3,997
3,951
3,895
3,930
3,786
3,634
3,571
3,633
3,773
3,940
3,793
3,840
3,386
3,313
3,256
3,054
2,886
3,126
3,175
3,165
3,092
3,216
3,152
3,129
3,256
3,049
3,157
3,397
3,3973,1573,0493,2563,1293,1523,2163,0923,1653,1753,1262,8863,0543,2563,3133,3863,8403,7933,9403,7733,6333,5713,6343,7863,9303,8953,9513,9974,3614,5834,4614,4014,2714,0313,9764,2104,1594,3213,7263,8323,7853,7084,4674,64928028028028000280000
       Long Term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
4,193
3,985
3,318
3,065
2,690
2,414
1,758
1,462
1,998
15,212
15,163
9,944
0
10,996
5,913
2,047
2,0475,91310,99609,94415,16315,2121,9981,4621,7582,4142,6903,0653,3183,9854,19300000000000000000000000000000000000000
       Intangible Assets 
0
0
0
42,074
0
0
40,697
39,883
39,410
39,050
38,572
38,098
37,618
37,126
36,653
36,175
39,703
39,139
47,522
46,331
41,962
41,598
41,330
40,679
40,267
39,089
38,730
38,316
38,360
37,788
37,353
37,519
36,901
36,638
36,604
36,675
36,450
36,209
35,806
35,557
35,180
34,646
34,151
34,172
34,004
622,438
616,259
610,079
603,912
597,720
591,540
587,611
581,371
575,102
575,102581,371587,611591,540597,720603,912610,079616,259622,43834,00434,17234,15134,64635,18035,55735,80636,20936,45036,67536,60436,63836,90137,51937,35337,78838,36038,31638,73039,08940,26740,67941,33041,59841,96246,33147,52239,13939,70336,17536,65337,12637,61838,09838,57239,05039,41039,88340,6970042,074000
       Other Assets 
0
0
0
2,067
0
0
0
49,158
49,254
49,050
51,841
53,085
55,629
55,780
54,787
72,041
76,880
78,626
86,699
90,698
86,806
88,698
88,228
81,548
38,971
40,009
40,585
40,536
42,910
34,261
33,077
37,029
35,427
36,870
50,919
50,884
32,192
34,424
33,606
39,064
38,700
41,082
42,948
59,383
0
61,137
0
0
0
0
0
0
0
0
0000000061,137059,38342,94841,08238,70039,06433,60634,42432,19250,88450,91936,87035,42737,02933,07734,26142,91040,53640,58540,00938,97181,54888,22888,69886,80690,69886,69978,62676,88072,04154,78755,78055,62953,08551,84149,05049,25449,1580002,067000
       Deferred Long Term Asset Charges 
0
0
0
0
0
0
0
0
0
6,118
6,118
6,932
9,856
9,907
9,938
27,444
27,444
27,444
27,423
31,001
31,874
31,874
31,874
27,745
28,257
28,257
29,458
30,618
30,618
20,746
20,746
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000000000000020,74620,74630,61830,61829,45828,25728,25727,74531,87431,87431,87431,00127,42327,44427,44427,4449,9389,9079,8566,9326,1186,118000000000
> Total Liabilities 
0
0
0
84,038
0
0
96,605
87,203
93,567
109,527
118,013
107,510
117,221
113,664
111,241
94,626
98,421
101,122
100,384
98,483
110,051
110,683
107,111
117,336
122,678
131,120
139,372
149,204
164,452
169,013
151,983
159,443
149,458
157,621
162,756
182,513
194,778
198,522
221,501
226,007
236,713
224,412
221,530
213,329
225,079
789,031
949,493
873,491
901,961
778,176
817,500
845,172
874,993
857,851
857,851874,993845,172817,500778,176901,961873,491949,493789,031225,079213,329221,530224,412236,713226,007221,501198,522194,778182,513162,756157,621149,458159,443151,983169,013164,452149,204139,372131,120122,678117,336107,111110,683110,05198,483100,384101,12298,42194,626111,241113,664117,221107,510118,013109,52793,56787,20396,6050084,038000
   > Total Current Liabilities 
0
0
0
60,075
0
0
78,447
65,402
72,813
56,282
63,082
62,595
72,090
69,404
70,653
59,955
64,921
65,667
60,837
60,617
72,861
63,701
57,397
67,192
72,542
87,590
96,621
106,834
111,959
100,999
86,596
90,009
83,371
93,286
96,717
112,201
127,096
124,549
97,989
103,810
114,364
103,634
102,190
94,862
105,635
251,285
257,963
225,407
255,169
136,971
159,010
173,759
199,052
176,407
176,407199,052173,759159,010136,971255,169225,407257,963251,285105,63594,862102,190103,634114,364103,81097,989124,549127,096112,20196,71793,28683,37190,00986,596100,999111,959106,83496,62187,59072,54267,19257,39763,70172,86160,61760,83765,66764,92159,95570,65369,40472,09062,59563,08256,28272,81365,40278,4470060,075000
       Short-term Debt 
0
0
0
0
0
0
23,091
22,104
31,888
10,665
10,078
7,594
12,531
12,632
14,762
10,934
11,177
10,904
8,541
5,366
5,263
6,205
6,212
6,312
6,061
18,891
18,592
18,229
22,707
12,415
13,149
10,916
18,420
19,037
19,445
15,620
19,577
14,551
7,980
5,184
8,717
8,687
8,046
6,049
8,150
19,186
4,152
4,342
4,370
4,245
4,461
7,038
7,970
8,806
8,8067,9707,0384,4614,2454,3704,3424,15219,1868,1506,0498,0468,6878,7175,1847,98014,55119,57715,62019,44519,03718,42010,91613,14912,41522,70718,22918,59218,8916,0616,3126,2126,2055,2635,3668,54110,90411,17710,93414,76212,63212,5317,59410,07810,66531,88822,10423,091000000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
7,594
0
0
0
10,934
0
10,904
8,541
5,366
5,263
46,312
6,212
5,985
6,061
18,891
18,592
17,886
17,587
6,941
6,969
7,741
11,458
12,075
12,167
12,263
12,173
8,077
2,256
2,202
2,159
2,057
1,680
3,046
2,168
12,920
433
436
428
249
252
234
224
927
92722423425224942843643312,9202,1683,0461,6802,0572,1592,2022,2568,07712,17312,26312,16712,07511,4587,7416,9696,94117,58717,88618,59218,8916,0615,9856,21246,3125,2635,3668,54110,904010,9340007,59400000000000
       Accounts payable 
0
0
0
17,663
0
0
14,540
20,380
17,571
17,764
10,013
10,161
18,948
18,447
12,265
13,872
18,619
18,767
13,439
16,196
19,302
14,910
9,590
16,629
15,631
21,663
22,668
31,323
34,273
31,462
22,044
25,061
16,506
21,708
23,170
24,357
22,987
27,752
21,658
22,214
23,843
31,071
19,963
20,501
21,979
18,832
31,970
25,438
36,534
31,775
34,088
30,514
52,813
41,881
41,88152,81330,51434,08831,77536,53425,43831,97018,83221,97920,50119,96331,07123,84322,21421,65827,75222,98724,35723,17021,70816,50625,06122,04431,46234,27331,32322,66821,66315,63116,6299,59014,91019,30216,19613,43918,76718,61913,87212,26518,44718,94810,16110,01317,76417,57120,38014,5400017,663000
       Other Current Liabilities 
0
0
0
42,412
0
0
40,816
19,428
20,041
24,437
25,604
27,704
30,725
31,210
40,889
31,430
30,225
27,683
31,817
31,350
40,197
36,364
37,414
40,926
42,867
45,429
53,694
56,095
53,962
53,972
50,003
51,990
45,451
50,196
52,483
71,147
81,856
78,615
64,391
67,331
68,688
63,279
72,650
63,741
63,916
195,571
190,749
194,018
208,408
99,437
115,112
126,543
123,127
124,117
124,117123,127126,543115,11299,437208,408194,018190,749195,57163,91663,74172,65063,27968,68867,33164,39178,61581,85671,14752,48350,19645,45151,99050,00353,97253,96256,09553,69445,42942,86740,92637,41436,36440,19731,35031,81727,68330,22531,43040,88931,21030,72527,70425,60424,43720,04119,42840,8160042,412000
   > Long-term Liabilities 
0
0
0
15,950
0
0
18,158
21,801
20,754
53,245
54,931
44,915
45,131
44,260
40,588
34,671
33,500
35,455
39,547
37,866
37,190
46,982
49,714
50,144
50,136
43,530
42,751
42,370
52,493
68,014
65,387
69,434
66,087
64,335
66,039
70,312
67,682
73,973
123,512
122,197
122,349
120,778
119,340
118,467
119,444
537,746
691,530
648,084
646,792
641,205
658,490
671,413
675,941
681,444
681,444675,941671,413658,490641,205646,792648,084691,530537,746119,444118,467119,340120,778122,349122,197123,51273,97367,68270,31266,03964,33566,08769,43465,38768,01452,49342,37042,75143,53050,13650,14449,71446,98237,19037,86639,54735,45533,50034,67140,58844,26045,13144,91554,93153,24520,75421,80118,1580015,950000
       Long term Debt Total 
0
0
0
0
0
0
0
0
0
42,850
41,271
36,106
35,886
34,798
31,354
30,165
29,092
31,742
34,163
32,356
31,148
40,107
42,232
40,844
39,706
33,695
32,606
31,984
30,973
39,793
38,079
39,394
36,410
34,622
32,903
34,186
32,334
30,460
75,552
74,776
74,348
73,871
74,011
72,839
72,872
488,280
0
0
0
0
0
0
0
0
00000000488,28072,87272,83974,01173,87174,34874,77675,55230,46032,33434,18632,90334,62236,41039,39438,07939,79330,97331,98432,60633,69539,70640,84442,23240,10731,14832,35634,16331,74229,09230,16531,35434,79835,88636,10641,27142,850000000000
       Deferred Long Term Asset Charges 
0
0
0
0
0
0
0
0
0
6,118
6,118
6,932
9,856
9,907
9,938
27,444
27,444
27,444
27,423
31,001
31,874
31,874
31,874
27,745
28,257
28,257
29,458
30,618
30,618
20,746
20,746
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000000000000020,74620,74630,61830,61829,45828,25728,25727,74531,87431,87431,87431,00127,42327,44427,44427,4449,9389,9079,8566,9326,1186,118000000000
       Other Liabilities 
0
0
0
4,992
0
0
0
4,578
3,988
3,241
2,934
2,971
3,406
3,624
3,396
4,506
4,408
3,713
3,768
4,055
4,569
5,337
5,896
7,939
10,430
9,835
10,145
10,386
10,346
10,467
10,368
13,725
14,447
15,183
15,602
18,662
18,884
18,958
22,494
22,718
22,512
22,227
20,963
21,934
0
25,059
0
0
0
0
0
0
0
0
0000000025,059021,93420,96322,22722,51222,71822,49418,95818,88418,66215,60215,18314,44713,72510,36810,46710,34610,38610,1459,83510,4307,9395,8965,3374,5694,0553,7683,7134,4084,5063,3963,6243,4062,9712,9343,2413,9884,5780004,992000
       Deferred Long Term Liability 
0
0
0
0
0
0
0
0
0
9,457
12,869
7,820
7,660
7,499
7,338
1,339
1,179
166
1,784
1,552
1,753
1,961
2,801
1,361
1,425
1,325
1,303
1,031
1,067
1,025
976
867
765
760
823
741
755
765
2,901
534
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000005342,9017657557418237607658679761,0251,0671,0311,3031,3251,4251,3612,8011,9611,7531,5521,7841661,1791,3397,3387,4997,6607,82012,8699,457000000000
> Total Stockholder Equity
0
0
0
233,439
233,439
0
248,792
251,545
251,542
287,741
283,120
281,860
279,281
285,265
283,786
295,510
296,585
307,464
328,453
329,255
325,561
333,314
330,655
337,329
327,104
320,526
319,416
332,435
334,986
387,845
389,405
381,366
377,514
397,681
405,232
402,306
405,558
421,993
430,176
445,522
479,525
499,307
505,165
528,658
548,577
589,235
595,140
639,421
672,356
713,346
727,678
732,298
751,283
757,482
757,482751,283732,298727,678713,346672,356639,421595,140589,235548,577528,658505,165499,307479,525445,522430,176421,993405,558402,306405,232397,681377,514381,366389,405387,845334,986332,435319,416320,526327,104337,329330,655333,314325,561329,255328,453307,464296,585295,510283,786285,265279,281281,860283,120287,741251,542251,545248,7920233,439233,439000
   Common Stock
0
0
0
4
0
0
4
4
4
4
4
4
4
5
5
5
5
5
5
5
5
5
5
5
5
5
5
5
5
5
5
5
5
5
5
5
6
6
6
6
6
6
6
6
6
6
6
6
6
6
6
6
6
6
666666666666666666555555555555555555555554444444004000
   Retained Earnings Total Equity
0
0
0
0
0
0
0
0
0
71,010
65,631
63,110
62,445
55,798
52,790
60,323
62,812
69,707
73,597
70,855
72,620
74,592
74,767
76,235
69,570
66,780
65,618
67,485
68,299
116,086
117,396
116,370
120,319
120,127
124,046
117,773
122,814
130,581
160,577
180,337
204,590
221,936
237,810
271,723
297,755
323,880
0
0
0
0
0
0
0
0
00000000323,880297,755271,723237,810221,936204,590180,337160,577130,581122,814117,773124,046120,127120,319116,370117,396116,08668,29967,48565,61866,78069,57076,23574,76774,59272,62070,85573,59769,70762,81260,32352,79055,79862,44563,11065,63171,010000000000
   Accumulated Other Comprehensive Income 
0
0
0
0
233,439
0
0
-90,575
-93,246
-268
-1,803
-1,654
-4,647
-4,134
-3,760
-2,475
-2,039
-2,690
-2,581
-4,696
-4,230
-3,220
-2,595
-2,100
-910
-3,166
-3,576
-4,013
-4,126
-4,223
-5,848
-4,687
-5,461
-5,173
-4,478
-3,721
-5,642
-4,931
-6,277
-6,765
-7,245
-8,709
-9,931
-8,624
-8,268
-8,324
-8,411
-8,478
-8,769
-8,826
-8,821
-9,181
-7,969
-5,361
-5,361-7,969-9,181-8,821-8,826-8,769-8,478-8,411-8,324-8,268-8,624-9,931-8,709-7,245-6,765-6,277-4,931-5,642-3,721-4,478-5,173-5,461-4,687-5,848-4,223-4,126-4,013-3,576-3,166-910-2,100-2,595-3,220-4,230-4,696-2,581-2,690-2,039-2,475-3,760-4,134-4,647-1,654-1,803-268-93,246-90,57500233,4390000
   Capital Surplus 
0
0
0
0
0
0
0
0
0
216,995
219,288
220,745
223,313
236,656
240,745
247,829
250,683
258,786
276,543
283,123
285,356
299,105
303,208
313,891
316,665
322,357
330,265
344,434
349,201
355,436
361,705
367,305
371,144
396,841
404,084
410,061
413,926
427,301
412,917
422,423
433,454
443,042
448,741
455,077
456,623
471,110
0
0
0
0
0
0
0
0
00000000471,110456,623455,077448,741443,042433,454422,423412,917427,301413,926410,061404,084396,841371,144367,305361,705355,436349,201344,434330,265322,357316,665313,891303,208299,105285,356283,123276,543258,786250,683247,829240,745236,656223,313220,745219,288216,995000000000
   Treasury Stock00000000-197,437-197,539-189,524-171,461-156,968-151,280-150,479-137,047-130,964-125,546-121,812-118,425-114,119-108,493-97,627-83,853-79,459-78,393-75,476-72,896-65,450-58,226-50,702-44,730-37,168-28,190-20,032-19,111-18,344-14,876-10,172-5,994-3,060-1,834-34500000000000
   Other Stockholders Equity 
0
0
0
171,488
0
0
176,808
177,732
179,348
216,995
219,288
220,400
221,479
233,596
234,751
237,657
235,807
240,442
257,432
263,091
257,166
261,937
258,478
263,189
258,439
256,907
257,369
268,958
270,808
275,977
277,852
269,678
262,651
282,722
285,659
288,249
288,380
296,337
275,870
271,944
282,174
286,074
277,280
265,553
259,084
273,673
230,443
238,625
228,674
231,772
205,670
172,686
165,175
137,735
137,735165,175172,686205,670231,772228,674238,625230,443273,673259,084265,553277,280286,074282,174271,944275,870296,337288,380288,249285,659282,722262,651269,678277,852275,977270,808268,958257,369256,907258,439263,189258,478261,937257,166263,091257,432240,442235,807237,657234,751233,596221,479220,400219,288216,995179,348177,732176,80800171,488000



5.4. Balance Sheets

Currency in USD. All numbers in thousands.




5.5. Cash Flows

Currency in USD. All numbers in thousands.




5.6. Income Statements

Currency in USD. All numbers in thousands.


5.7. Latest Income Statement

Income Statement (annual), 2024-12-31. Currency in USD. All numbers in thousands.

Gross Profit (+$)
totalRevenue712,814
Cost of Revenue-338,959
Gross Profit373,855373,855
 
Operating Income (+$)
Gross Profit373,855
Operating Expense-168,436
Operating Income205,419205,419
 
Operating Expense (+$)
Research Development73,914
Selling General Administrative56,720
Selling And Marketing Expenses37,802
Operating Expense168,436168,436
 
Net Interest Income (+$)
Interest Income10,612
Interest Expense-30,343
Other Finance Cost-0
Net Interest Income-19,731
 
Pretax Income (+$)
Operating Income205,419
Net Interest Income-19,731
Other Non-Operating Income Expenses0
Income Before Tax (EBT)189,764221,074
EBIT - interestExpense = 189,764
189,191
189,862
Interest Expense30,343
Earnings Before Interest and Taxes (EBIT)220,107220,107
Earnings Before Interest and Taxes (EBITDA)277,312
 
After tax Income (+$)
Income Before Tax189,764
Tax Provision-29,672
Net Income From Continuing Ops159,519160,092
Net Income159,519
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses507,395
Total Other Income/Expenses Net-15,65519,731
 

Technical Analysis of Amphastar
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Amphastar. The general trend of Amphastar is UNKNOWN with 0.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Amphastar's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator StateBullish trend Bearish trend
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Amphastar Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Amphastar P.

The long score for the Support & Resistance is 1/1.
The longshort score for the Support & Resistance is 1/(-1 +1).

  • Around support: The price is currently trading around a support level. This can be considered as a potential entry level. +1

The bullish price targets are: 29.42 < 31.23 < 31.26.

The bearish price targets are: 27.40 > 22.90 > 20.43.

Know someone who trades $AMPH? Share this with them.👇

Amphastar P Daily Support & Resistance Chart
3rd party ad coffee SUPPORTERis ad-free.

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Amphastar P. The current mas is .

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Amphastar P Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Amphastar P.

Amphastar P Daily Moving Average Convergence/Divergence (MACD) ChartAmphastar P Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Amphastar P. The current adx is .

Amphastar P Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Amphastar P.

Amphastar P Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Amphastar P.

Amphastar P Daily Relative Strength Index (RSI) ChartAmphastar P Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Amphastar P.

Amphastar P Daily Stochastic Oscillator ChartAmphastar P Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Amphastar P.

Amphastar P Daily Commodity Channel Index (CCI) ChartAmphastar P Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Amphastar P.

Amphastar P Daily Chande Momentum Oscillator (CMO) ChartAmphastar P Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Amphastar P.

Amphastar P Daily Williams %R ChartAmphastar P Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Amphastar P.

Amphastar P Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Amphastar P.

Amphastar P Daily Average True Range (ATR) ChartAmphastar P Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Amphastar P.

Amphastar P Daily On-Balance Volume (OBV) ChartAmphastar P Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Amphastar P.

Amphastar P Daily Money Flow Index (MFI) ChartAmphastar P Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Amphastar P.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2025-05-01STOCH LONG EXITThe %K line crosses below the %D line.
2025-05-02STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-05-05CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-05-06STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-05-08STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-05-09SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-05-14WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-05-15STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-05-16DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2025-05-20SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-05-21DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-05-23STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-05-27DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-06-02STOCH LONG EXITThe %K line crosses below the %D line.
2025-06-03STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-06-04STOCH LONG EXITThe %K line crosses below the %D line.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2025-06-05MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2025-06-06STOCH SHORT EXITThe %K line crosses above the %D line.
2025-06-09CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-06-11STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-06-12SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2025-06-17MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-06-18DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-06-20CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-06-23STOCH SHORT EXITThe %K line crosses above the %D line.
2025-06-24STOCH LONG EXITThe %K line crosses below the %D line.
2025-06-25BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-06-27STOCH SHORT EXITThe %K line crosses above the %D line.
2025-06-30STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2025-07-01SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
2025-07-03STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-07-07SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2025-07-09STOCH SHORT EXITThe %K line crosses above the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-07-10STOCH LONG EXITThe %K line crosses below the %D line.
2025-07-11STOCH SHORT EXITThe %K line crosses above the %D line.
2025-07-14RSI LONG ENTRY SHORT CLOSE30 crossover to upside
2025-07-15STOCH LONG EXITThe %K line crosses below the %D line.
2025-07-17RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
2025-07-18STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-07-21RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
2025-07-23MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2025-07-28DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-07-29DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
2025-07-31SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-08-01STOCH SHORT EXITThe %K line crosses above the %D line.
2025-08-06STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-08-07STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-08-08DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-08-11WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-08-12ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-08-13STOCH LONG EXITThe %K line crosses below the %D line.
2025-08-19STOCH SHORT EXITThe %K line crosses above the %D line.
2025-08-20STOCH LONG EXITThe %K line crosses below the %D line.
2025-08-22STOCH SHORT EXITThe %K line crosses above the %D line.
2025-08-25RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
2025-08-26STOCH SHORT EXITThe %K line crosses above the %D line.
2025-08-28RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
2025-09-03MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
RSI SHORT ENTRY LONG CLOSE70 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-09-05STOCH SHORT EXITThe %K line crosses above the %D line.
2025-09-08SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2025-09-09CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-09-10STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2025-09-12DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.

6.3. Candlestick Patterns

Amphastar P Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Amphastar P based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
OpenGreater thanClose27.300
Total1/1 (100.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of Amphastar with someone you think should read this too:
  • Are you bullish or bearish on Amphastar? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Amphastar? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Amphastar P

I send you an email if I find something interesting about Amphastar P.


Comments

How you think about this?

Leave a comment

Stay informed about Amphastar P.

Receive notifications about Amphastar P in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.